DK3334412T3 - Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet - Google Patents
Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet Download PDFInfo
- Publication number
- DK3334412T3 DK3334412T3 DK16797943.4T DK16797943T DK3334412T3 DK 3334412 T3 DK3334412 T3 DK 3334412T3 DK 16797943 T DK16797943 T DK 16797943T DK 3334412 T3 DK3334412 T3 DK 3334412T3
- Authority
- DK
- Denmark
- Prior art keywords
- electrohydrodynamic
- residence
- fibers
- acquired
- increased
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nonwoven Fabrics (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201570745 | 2015-11-19 | ||
| PCT/EP2016/078151 WO2017085264A1 (en) | 2015-11-19 | 2016-11-18 | A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3334412T3 true DK3334412T3 (da) | 2022-01-17 |
Family
ID=58718438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16797943.4T DK3334412T3 (da) | 2015-11-19 | 2016-11-18 | Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US20180221295A1 (da) |
| EP (1) | EP3334412B1 (da) |
| JP (2) | JP6606279B2 (da) |
| KR (3) | KR102001163B1 (da) |
| CN (1) | CN108135833B (da) |
| AU (2) | AU2016358266B2 (da) |
| BR (1) | BR112018001978A2 (da) |
| CA (1) | CA2993377C (da) |
| DK (1) | DK3334412T3 (da) |
| ES (1) | ES2900741T3 (da) |
| HK (1) | HK1256209A1 (da) |
| IL (1) | IL258093B (da) |
| MX (1) | MX2018005206A (da) |
| MY (1) | MY167777A (da) |
| NZ (1) | NZ740615A (da) |
| RU (2) | RU2701513C2 (da) |
| SG (1) | SG10201913222XA (da) |
| WO (1) | WO2017085264A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019126497A (ru) | 2017-01-23 | 2021-02-24 | Афикс Терапьютикс А/С | Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества |
| ES2887977T3 (es) | 2017-01-23 | 2021-12-29 | Afyx Therapeutics As | Método para la fabricación de un producto de dos capas a base de fibras electrohiladas |
| WO2021050532A1 (en) * | 2019-09-09 | 2021-03-18 | Afyx Therapeutics A/S | Compositions for treating fungal infections |
| CA3157209A1 (en) | 2019-10-08 | 2021-04-15 | Afyx Therapeutics A/S | Compositions for the delivery of proteins |
| JP2023517987A (ja) * | 2020-03-17 | 2023-04-27 | アーロン エイチ． ブレイジー， | 延長された薬物放出のための膨張可能なマルチ賦形剤の構造化された剤形 |
| EP4108231A1 (en) * | 2021-06-25 | 2022-12-28 | Johann-Wolfgang-Goethe-Universität Frankfurt am Main | In-situ dissolving electrospun polymer fibers for ocular drug delivery |
| PL4124336T3 (pl) * | 2021-07-30 | 2024-02-26 | Cannamedical Pharma Gmbh | Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid |
| CA3239200A1 (en) | 2021-11-23 | 2023-06-01 | Afyx Development A/S | Mucosal patches and methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61280423A (ja) | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
| US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
| PL356924A1 (en) * | 2000-01-28 | 2004-07-12 | Smithkline Beecham Corporation | Electrospun pharmaceutical compositions |
| US7309498B2 (en) * | 2001-10-10 | 2007-12-18 | Belenkaya Bronislava G | Biodegradable absorbents and methods of preparation |
| US20030017208A1 (en) * | 2002-07-19 | 2003-01-23 | Francis Ignatious | Electrospun pharmaceutical compositions |
| TW200410714A (en) * | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
| WO2004014448A1 (en) * | 2002-08-13 | 2004-02-19 | Medtronic, Inc. | Active agent delivery system including a hydrophilic polymer, medical device, and method |
| US9233080B2 (en) * | 2008-03-27 | 2016-01-12 | Agigma, Inc. | Compositions and methods for the delivery of agents |
| US20130295143A1 (en) * | 2012-05-02 | 2013-11-07 | Massachusetts Institute Of Technology | Electroprocessing of active pharmaceutical ingredients |
| CN102670483B (zh) * | 2012-05-09 | 2014-04-02 | 上海交通大学 | 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法 |
| WO2014066297A1 (en) * | 2012-10-22 | 2014-05-01 | North Carolina State University | Nonwoven fiber materials |
| EP2810645B1 (en) * | 2013-06-06 | 2017-05-24 | A. Sezai Sarac | New Drug Delivery System |
| US10052291B2 (en) * | 2014-06-10 | 2018-08-21 | Dermtreat Aps | Compositions comprising electrohydrodynamically obtained fibres for administration of specific doses of an active substance to skin or mucosa |
-
2016
- 2016-11-18 CA CA2993377A patent/CA2993377C/en active Active
- 2016-11-18 SG SG10201913222XA patent/SG10201913222XA/en unknown
- 2016-11-18 ES ES16797943T patent/ES2900741T3/es active Active
- 2016-11-18 RU RU2018109496A patent/RU2701513C2/ru active
- 2016-11-18 DK DK16797943.4T patent/DK3334412T3/da active
- 2016-11-18 KR KR1020187008505A patent/KR102001163B1/ko active IP Right Grant
- 2016-11-18 RU RU2019129082A patent/RU2019129082A/ru unknown
- 2016-11-18 BR BR112018001978A patent/BR112018001978A2/pt not_active Application Discontinuation
- 2016-11-18 JP JP2018516015A patent/JP6606279B2/ja active Active
- 2016-11-18 NZ NZ740615A patent/NZ740615A/en unknown
- 2016-11-18 MY MYPI2018700176A patent/MY167777A/en unknown
- 2016-11-18 EP EP16797943.4A patent/EP3334412B1/en active Active
- 2016-11-18 KR KR1020197004754A patent/KR102435996B1/ko active IP Right Grant
- 2016-11-18 MX MX2018005206A patent/MX2018005206A/es unknown
- 2016-11-18 AU AU2016358266A patent/AU2016358266B2/en active Active
- 2016-11-18 WO PCT/EP2016/078151 patent/WO2017085264A1/en active Application Filing
- 2016-11-18 CN CN201680046647.5A patent/CN108135833B/zh active Active
- 2016-11-18 KR KR1020197016484A patent/KR20190067280A/ko active Application Filing
-
2018
- 2018-01-29 US US15/882,637 patent/US20180221295A1/en not_active Abandoned
- 2018-03-13 IL IL258093A patent/IL258093B/en unknown
- 2018-08-21 AU AU2018220020A patent/AU2018220020C1/en active Active
- 2018-11-29 HK HK18115318.3A patent/HK1256209A1/zh unknown
-
2019
- 2019-04-24 US US16/393,597 patent/US20190254985A1/en not_active Abandoned
- 2019-10-16 JP JP2019189500A patent/JP6929916B2/ja active Active
-
2023
- 2023-05-17 US US18/198,582 patent/US20230285313A1/en not_active Abandoned
-
2024
- 2024-01-05 US US18/406,022 patent/US20240139117A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3334412T3 (da) | Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet | |
| ES2821790T8 (es) | Moduladores de la vía de estrés integrada | |
| BR112018001310A2 (pt) | composições ingeríveis por abelha, métodos de uso das mesmas para a produção de mel e mel produzido por estas | |
| MA40587A (fr) | Composés d'aminopyrimidinyle en tant qu'inhibiteurs de jak | |
| DK3297605T3 (da) | Topiske, farmaceutiske sammesætninger | |
| DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3229810T3 (da) | Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler | |
| DK3482543T3 (da) | Observationssystem | |
| DK3163339T3 (da) | Polariseringsbevarende multikernefiber | |
| DK3256462T3 (da) | Substituerede 2-thioimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
| FI20155406A (fi) | Moolimassasäädelty selluloosa | |
| MA41169A (fr) | Composés antibactériens à large spectre d'activité | |
| FR3019737B1 (fr) | Composition cosmetique de revetement des fibres keratiniques. | |
| DK3137053T3 (da) | Formuleringer af biologiske lægemidler til intravesikal instillation | |
| DK3246736T3 (da) | Optisk fiber | |
| FR3038827B1 (fr) | Ensemble d’instrumentation chirurgicale | |
| ES1239889Y (es) | Fibra de viscosa modificada | |
| DK3359713T3 (da) | Kompositfiber | |
| BR112016029232A2 (pt) | estruturas que compreendem fibras poliméricas | |
| DK3079688T3 (da) | Chromonderivat som en dopamin-d3-receptorantagonist til anvendelse ved behandling af autismespektrumforstyrrelse | |
| KR20180084784A (ko) | 마찰 공학적 응용을 위한 섬유 | |
| BR112017007509A2 (pt) | Processo para a preparação de 1-(3,5-dicloro-4- fluoro-fenil)-2,2,2-trifluoro-etanona | |
| CL2019001712A1 (es) | Un monofilamento de fibra. | |
| BR112017024896A2 (pt) | polímeros para revestimentos repelentes à sujidade. | |
| DK3334856T3 (da) | Phosphoneret pbi-fiber |